Navigation Links
Arena Submits Response to FDA Complete Response Letter for Lorcaserin
Date:1/3/2012

SAN DIEGO and WOODCLIFF LAKE, N.J., Jan. 3, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that Arena has submitted its response to the Complete Response Letter (CRL) issued by the US Food and Drug Administration (FDA) following review of the lorcaserin New Drug Application (NDA). Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (Body Mass Index, or BMI, >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition. The companies expect that later this month the FDA will confirm acceptance of the response and assign a new Prescription Drug User Fee Act (PDUFA) date.

"We have worked diligently with Eisai to prepare this submission that we believe will address the issues raised in the complete response letter," said Jack Lief, Arena's President and Chief Executive Officer. "We look forward to providing on today's call an overview of the submission contents, including the results of the recently completed rat mechanistic studies, which we believe provide additional data supporting lorcaserin's benefit-risk profile."

Lonnel Coats, President and Chief Executive Officer of Eisai Inc., said, "Weight loss for obese patients and overweight patients with co-morbid conditions remains an area of unmet need. Eisai is pleased to collaborate with Arena in its response to the FDA, an important milestone toward lorcaserin's potential approval."

The response to the lorcaserin CRL includes data and analyses that were not incorporated in the original NDA, including the results of Arena's Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) clinical trial, which evaluated lorcaserin for weight loss in patients with type 2 diabetes. The new
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
2. Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
3. Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
4. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
5. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
6. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
7. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
8. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
10. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
11. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... -- Within just two years after reaching a milestone ... 3,000 employees worldwide. This increase is reflecting a ... delivery market and SHL,s effective commitment, productivity and ... design and manufacturing of auto injectors and pen ... a lean supply chain, strong partnerships, and more. ...
(Date:9/1/2015)... , Aug. 31, 2015 Research ... addition of the "Introduction to Veterinary Pharmacovigilance ... their offering. This course has ... good introduction to those concerned with Veterinary Pharmacovigilance. ... personnel who reqire a better understanding of veterinay ...
(Date:9/1/2015)... 2015 - The ... egistry data presented at ESC Congress ... the evolution of manag ing AF in ... -   The first-ever two-year outcomes from the Global Anticoagulant ... expose that all-cause death was the most frequent major event in more than ...
Breaking Medicine Technology:SHL Group Reaches Major Milestone of 3000 Employees 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
... 2012  Before purchasing electronic health records software ... management features, supported architectures and the ONC-ATCB certification ... consists of health information compiled from multiple health-oriented ... contains a patient,s medical information from one organization, ...
... Inc. (NYSE: PRX ) announced today that it will ... 2012 at 9:00 AM EST to review results for the fourth ... results on February 28, 2012 before the market opens. ... website at www.parpharm.com . Dial-in Information ...
Cached Medicine Technology:Let FindTheBest Help You Choose The Best Electronic Health Record Software 2
(Date:9/1/2015)... ... September 01, 2015 , ... As part ... and Blue Shield of Minnesota (Blue Cross) has announced Doctor On Demand as ... San Francisco, Doctor On Demand provides immediate access to Board Certified physicians or ...
(Date:9/1/2015)... ... 2015 , ... Virginia entrepreneur Marcella Ellis, CEO and founder ... firm’s success in the hair care and distribution industry through her combination of ... be providing “Look and learn” live demonstrations, as well as promoting her new ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... has announced that Edge Information Management has been granted continued accreditation ... Credentialing Council (BSCC). , “Achieving and maintaining this accreditation takes the ...
(Date:9/1/2015)... ... ... With former IBMers among its founding members, Inmar has known the value of ... ago. A pilot program begun by the company in 2014 has proved popular with ... pursuing careers in these fields. The program is now open to area middle and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent natural ... women for 19 years and found that, among those who had a stroke, people ... report is part of the September 2015 issue of “Natural Insights for Well Being,” ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... Provides Important Tool to Fight Pandemic , , ... that it has approved four vaccines against the 2009 H1N1 influenza virus. ... which is expected within the next four weeks. , , ... , "Today,s approval is good news for our nation,s response ...
... have little effect on risk factor for heart disease, ... In people with newly diagnosed type 2 diabetes, the ... the inflammation associated with heart disease, new research suggests. ... the researchers found they didn,t affect inflammatory markers any ...
... Agency expects first batches to be available within a month ... and Drug Administration on Tuesday approved four new H1N1 swine ... within four weeks. , "Today,s approval is good news for ... Commissioner Dr. Margaret A. Hamburg said in a news release. ...
... , WASHINGTON, Sept. 15 ... progressives, a majority of liberals oppose extending taxpayer-funded healthcare to ... a universal plan and agree with the President,s handling of ... healthcare coverage to illegal aliens and result in increased costs. ...
... , NASHVILLE, Tenn., Sept. 15 ... named to the InformationWeek 500, which lists the nation,s most innovative ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ) , ... September 14, 2009 at an awards ceremony held during the InformationWeek ...
... 15, 2009) A research project looking for ways to ... the bone health of cancer patients undergoing radiation treatment. ... of space causes bone loss in astronauts, but until recently, ... bones. Dr. Ted Bateman leads a project funded by the ...
Cached Medicine News:Health News:FDA Approves Vaccines for 2009 H1N1 Influenza Virus 2Health News:FDA Approves Vaccines for 2009 H1N1 Influenza Virus 3Health News:Diabetes Medications Don't Lower Inflammation 2Health News:Diabetes Medications Don't Lower Inflammation 3Health News:FDA Approves 4 Swine Flu Vaccines 2Health News:FDA Approves 4 Swine Flu Vaccines 3Health News:FDA Approves 4 Swine Flu Vaccines 4Health News:Poll: Liberals Oppose Healthcare for Illegal Aliens 2Health News:Hospital Corporation of America Recognized by InformationWeek as One of Nation's Most Innovative Users of Business Technology 2Health News:Space-related radiation research could help reduce fractures in cancer survivors 2Health News:Space-related radiation research could help reduce fractures in cancer survivors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: